Express News | Shanghai aims to nurture around 10 internationally competitive listed companies in key industries such as integrated circuits, biomedical, and new materials by 2027, forming a merger and acquisition trade scale of 300 billion yuan.

BreakingsDec 10 15:15

The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!

Industry pessimistic expectations may improve.

Gelonghui FinanceDec 9 12:10

How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.

① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.

cls.cnDec 8 16:48

Junshi bio (01877) has nominated Li Zhongxian and Lu Kun as candidates for independent non-executive directors.

junshi bio (01877) announced that the board of directors has considered and approved the nomination of Li Zhongxian and Lu Kun as independent non-executive directors of the company...

Zhitong FinanceNov 29 20:45

Express News | Hong Kong biomedical stocks fluctuated higher in the afternoon, with Beigene rising nearly 6%, Junshi Bio and Wuxi XDC both up over 4%, and Tigermed, Wuxi Bio, and zai lab increasing by more than 3%.

BreakingsNov 29 13:17

Junshi Biosciences' Teplizumab Injection Included in China's 2025 Drug Insurance Catalog; Shares Up 6%

MT NewswiresNov 29 12:13